Amicus Brief Addresses PTAB Review of Obviousness-Type Double Patenting and Patent Term Issues Affecting Biotech ...

Looking back on biotechnology stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Incyte ...

The average one-year price target for Nautilus Biotechnology (NasdaqCM:NAUT) has been revised to $4.08 / share. This is an ...

Insilico Medicine ("Insilico", 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven biotechnology ...

Shares Biotechnology ETF (IBB) gives investors biotech exposure through large, established drug developers rather than ...

Curative Biotechnology, Inc. (OTC: CUBTD) ("Curative” or the "Company”), a development-stage biomedical company focused on novel treatments for degenerative eye diseases, today announced a reverse ...

Biotech stocks surged in 2025, driven by FDA approvals, M&A activity, and rising longevity investment. Explore key trends, ...

PDS Biotechnology Corporation (PDSB) on Monday reported a loss of $7.6 million in its fourth quarter. The East Princeton, New Jersey-based company said it had a loss of 14 cents per share. For the ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine, as global R&D investment approaches $360 billion ...

Vir Biotechnology Reports Positive Updated Phase 1 Results for PSMA-targeting, PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 in Patients with Metastatic Prostate Cancer – Updated Phase 1 ...

In the rapidly evolving field of industrial biotechnology, bacteria have emerged as crucial agents driving innovation and sustainable development.

Explore the Scaling Biotechnology and Novel Foods report to discover how industry leaders overcome regulatory, manufacturing ...